Myostatin inhibitors funded for muscle regeneration of war injuries
A $1.2 million grant from the Office of Naval Research to Dr. Hamrick,bone biologist in the Medical College of Georgia Schools of Graduate Studies and Medicine, is enabling laboratory studies of two experimental myostatin inhibitors: a decoy receptor and a binding protein, both developed by MetaMorphix, Inc. of Beltsville, Md. Both inhibitors have been shown …